SavedAdd your journal

Journals / Respiratory Case Reports / 2016 / Cilt: 5 - Sayı: 2

Pulmonary Toxicity Due to Low-Dose Amiodarone Usage

Düşük Doz Amiodaron Kullanımına Bağlı Pulmoner Toksisite

Fatmanur ÇELİK BAŞARAN
Canan DOĞAN
Ayşe ÖZSÖZ
Pages
117–120
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we present a case of successfully treated pulmonary toxicity which developed after low-dose amiodarone.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Amiodarone is a group III anti-arrhythmic drug which is used for arrhythmia.
📊
Key Findings & Data:The pulmonary toxicity due to amiodarone is the major complication which threats the life.
💡
Conclusion & Impact:In this report, we present a case of successfully treated pulmonary toxicity which developed after low-dose amiodarone.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Amiodarone is a group III anti-arrhythmic drug which is used for arrhythmia. The pulmonary toxicity due to amiodarone is the major complication which threats the life. Long-term and high dose usage causes pulmonary toxicity. In this report, we present a case of successfully treated pulmonary toxicity which developed after low-dose amiodarone.

Özet

Amiodaron aritmi tedavisinde kullanılan grup III antiaritmiktir. Amiodarona bağlı pulmoner toksisite uzun süreli ve yüksek doz kullanımda ortaya çıkan, hayatı tehdit eden bir komplikasyondur. Bu yazıda, düşük doz amiodaron kullanımına bağlı olarak pulmoner toksisite gelişen ve başarı ile tedavi edilen bir olguyu sunduk.

🔖

Cite This Article

BAŞARAN, F. Ç., DOĞAN, C., ÖZSÖZ, A. (2016). Pulmonary Toxicity Due to Low-Dose Amiodarone Usage. Respiratory Case Reports, Cilt: 5 - Sayı: 2, 117–120. https://ajindex.com/articles/302577

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kasapoğlu US, Irmak İ, Arınç S, Atagün GP, Hazar AF. Sulfazalazine-induced lung disease: a case report. Respir Case Rep 2015; 4:10-2. [CrossRef] 2. Kararmaz A, Çorman P, Çelikoğlu F. Amiodaron'a bağlı ender bir komplikasyon; yaygın alveolar hemoraji. GKDA Derg 2014; 20:55-8. [CrossRef] 3. Kalemci S, Şimşek G, Sevinç C. Düşük doz amiodaron kullanımına ikincil gelişen pulmoner toksisite. Harran Üniversitesi Tıp Fakültesi Dergisi 2012; 9:36-7. 4. Camus P, Martin WJ 2nd, Rosenow EC 3rd. Amiodarone pulmonary toxicity. Clin Chest Med 2004; 25:65-75. [CrossRef] 5. Ott MC, Khoor A, Leventhal JP, Paterick TE, Burger CD, Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 2003; 123:646-51. [CrossRef] 6. Kennedy JI, Myers JL, Plumb VJ, Fulmer JD. Amiodarone pulmonary toxicity: clinical, radiologic and pathologic correlations. Arch Intern Med 1987; 147:50-5. [CrossRef] 7. Yeşilova Z, Kantarcioğlu M, Erçin CN, Safalioğlu M, Kilciler G, Koç E ve ark. Sulfasalazine-induced hypersensitivity: a case report of DRESS syndrome. Turk J Gastroenterol 2009; 20:298-9. [CrossRef]